Stocktoria

Sensei Biotherapeutics, Inc. FTH

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-02-04

Sensei Biotherapeutics, Inc. statistics & valuation

P / B1.0×

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Return on assets-92.1%-66.5%-45.9%-41.0%-24.0%
Return on equity-113.4%-78.6%-52.5%-47.0%-25.1%
Current ratio5.067.7011.9211.9830.38

Source: SEC EDGAR filings · CIK 0001829802 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.